Damloran Pharmaceutical (XTEH:DAML1) EBITDA Margin %: 0.00% (As of . 20)


XTEH:DAML1 Damloran Pharmaceutical XTEH:DAML1
27 GF Score
Price IRR10,100.00
View Full Analysis

What is Damloran Pharmaceutical EBITDA Margin %?

Damloran Pharmaceutical XTEH:DAML1 27 EBITDA Margin % is 0.00% as of . 20. GuruFocus rates XTEH:DAML1 with a GF Score™ of 27/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Damloran Pharmaceutical's EBITDA for the six months ended in . 20 was IRR0.00 Mil. Damloran Pharmaceutical's Revenue for the six months ended in . 20 was IRR0.00 Mil. Therefore, Damloran Pharmaceutical's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Damloran Pharmaceutical  (XTEH:DAML1) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Damloran Pharmaceutical EBITDA Margin % Related Terms

Damloran Pharmaceutical EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Damloran Pharmaceutical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Damloran Pharmaceutical EBITDA Margin % Chart

Damloran Pharmaceutical Annual Data
Trend
EBITDA Margin %

Damloran Pharmaceutical Semi-Annual Data
EBITDA Margin %

XTEH:DAML1 vs IMNPQ: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Damloran Pharmaceutical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Damloran Pharmaceutical EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Damloran Pharmaceutical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Damloran Pharmaceutical's EBITDA Margin % falls into.


XTEH:DAML1
27GF Score
Damloran Pharmaceutical XTEH:DAML1
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Damloran Pharmaceutical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Damloran Pharmaceutical's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Damloran Pharmaceutical's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Damloran Pharmaceutical (XTEH:DAML1) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Damloran Pharmaceutical and its competitors.
Is Damloran Pharmaceutical's EBITDA Margin % too high?
Damloran Pharmaceutical's current EBITDA Margin % is 0.00%. Overall, Damloran Pharmaceutical has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Damloran Pharmaceutical's EBITDA Margin % compare to IMNPQ?
Damloran Pharmaceutical's EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.52, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Damloran Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Damloran Pharmaceutical's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Damloran Pharmaceutical stock overvalued right now?
Damloran Pharmaceutical (XTEH:DAML1) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Damloran Pharmaceutical's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Damloran Pharmaceutical (XTEH:DAML1), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Damloran Pharmaceutical Business Description

Address No.4, Parvin Alley, West Fatemi Avenue, Tehran, IRN
Damloran Pharmaceutical manufactures and markets livestock and poultry pharmaceuticals. The Company offers animal health products to protect and improve health and hygiene of society to treat and to enhance the quality of animals' life.
27GF Score

Get the complete analysis for XTEH:DAML1

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

IRR10,100.00
Price